A comprehensive research effort is needed to address increasingly complex issues of cancer survivorship, especially with respect to the extremely high rate of second cancers. This increasingly large and high-risk population represents an outstanding opportunity for novel cancer screening strategies, the development of targeted chemopreventive agents and vaccines, as well as more sensitive and precise biomarkers of risk and early detection. In this special section of Cancer Epidemiology, Biomarkers, and Prevention are presented articles from Drs. Lois Travis, Susan Mayne, and Victor Vogel, who participated as invited speakers in an American Society of Oncology/AACR-sponsored mini symposium entitled ''Second Cancers Are Killing Us!'' at the AACR's Frontiers in Cancer Prevention fourth annual meeting in Baltimore, MD in November, 2005. It is anticipated that these three articles, covering the epidemiology, screening, and chemoprevention of second primary cancers will serve to ignite interest in multiple research areas about the long-term follow up and management of the ever increasing population of cancer survivors in the United States.
